Your browser doesn't support javascript.
loading
Natural history of disease in cynomolgus monkeys exposed to Ebola virus Kikwit strain demonstrates the reliability of this non-human primate model for Ebola virus disease.
Niemuth, Nancy A; Fallacara, Dawn; Triplett, Cheryl A; Tamrakar, Sanjay M; Rajbhandari, Alisha; Florence, Clint; Ward, Lucy; Griffiths, Anthony; Carrion, Ricardo; Goez-Gazi, Yenny; Alfson, Kendra J; Staples, Hilary M; Brasel, Trevor; Comer, Jason E; Massey, Shane; Smith, Jeanon; Kocsis, Andrew; Lowry, Jake; Johnston, Sara C; Nalca, Aysegul; Goff, Arthur J; Shurtleff, Amy C; Pitt, Margaret L; Trefry, John; Fay, Michael P.
Afiliación
  • Niemuth NA; Battelle, Columbus, OH, United States of America.
  • Fallacara D; Battelle, Columbus, OH, United States of America.
  • Triplett CA; Battelle, Columbus, OH, United States of America.
  • Tamrakar SM; Battelle, Columbus, OH, United States of America.
  • Rajbhandari A; Battelle, Columbus, OH, United States of America.
  • Florence C; Non-Clinical Advisor for Joint Program Manager Chemical, Biological, Radiological and Nuclear Medical (JPM CBRN Medical) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO CBRND), Fort Detrick, MD, United States of America.
  • Ward L; Advanced Vaccines & Immunologics, JPM CBRN Medical, JPEO CBRND, Fort Detrick, MD, United States of America.
  • Griffiths A; Department of Microbiology, National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, United States of America.
  • Carrion R; Texas Biomedical Research Institute, San Antonio, TX, United States of America.
  • Goez-Gazi Y; Texas Biomedical Research Institute, San Antonio, TX, United States of America.
  • Alfson KJ; Texas Biomedical Research Institute, San Antonio, TX, United States of America.
  • Staples HM; Texas Biomedical Research Institute, San Antonio, TX, United States of America.
  • Brasel T; Department of Microbiology and Immunology/Institutional Office of Regulated Nonclinical Studies, University of Texas Medical Branch (UTMB), Galveston, TX, United States of America.
  • Comer JE; Department of Microbiology and Immunology/Institutional Office of Regulated Nonclinical Studies, University of Texas Medical Branch (UTMB), Galveston, TX, United States of America.
  • Massey S; Institutional Office of Regulated Nonclinical Studies, UTMB, Galveston, TX, United States of America.
  • Smith J; Institutional Office of Regulated Nonclinical Studies, UTMB, Galveston, TX, United States of America.
  • Kocsis A; Animal Resources Center, UTMB. Galveston, TX, United States of America.
  • Lowry J; Animal Resources Center, UTMB. Galveston, TX, United States of America.
  • Johnston SC; Virology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, MD, United States of America.
  • Nalca A; Core Support Directorate, USAMRIID, Fort Detrick, MD, United States of America.
  • Goff AJ; Commander's Special Staff, Deputy Director Research Program Office, USAMRIID, Fort Detrick, MD, United States of America.
  • Shurtleff AC; Molecular Biology Division, USAMRIID, Fort Detrick, MD, United States of America.
  • Pitt ML; USAMRIID, Fort Detrick, MD, United States of America.
  • Trefry J; Vaccines/Therapeutics Division (CBM), Defense Threat Reduction Agency, Fort Belvoir, Virginia, United States of America.
  • Fay MP; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
PLoS One ; 16(7): e0252874, 2021.
Article en En | MEDLINE | ID: mdl-34214118
ABSTRACT
Filoviruses (Family Filoviridae genera Ebolavirus and Marburgvirus) are negative-stranded RNA viruses that cause severe health effects in humans and non-human primates, including death. Except in outbreak settings, vaccines and other medical countermeasures against Ebola virus (EBOV) will require testing under the FDA Animal Rule. Multiple vaccine candidates have been evaluated using cynomolgus monkeys (CM) exposed to EBOV Kikwit strain. To the best of our knowledge, however, animal model development data supporting the use of CM in vaccine research have not been submitted to the FDA. This study describes a large CM database (122 CM, 62 female and 60 male, age 2 to 9 years) and demonstrates the consistency of the CM model through time to death models and descriptive statistics. CMs were exposed to EBOV doses of 0.1 to 100,000 PFU in 33 studies conducted at three Animal Biosafety Level 4 facilities, by three exposure routes. Time to death was modeled using Cox proportional hazards models with a frailty term that incorporated study-to-study variability. Despite significant differences attributed to exposure variables, all CMs exposed to the 100 to 1,000 pfu doses commonly used in vaccine studies died or met euthanasia criteria within 21 days of exposure, median 7 days, 93% between 5 and 12 days of exposure. Moderate clinical signs were observed 4 to 5 days after exposure and preceded death or euthanasia by approximately one day. Viremia was detected within a few days of infection. Hematology indices were indicative of viremia and the propensity for hemorrhage with progression of Ebola viremia. Changes associated with coagulation parameters and platelets were consistent with coagulation disruption. Changes in leukocyte profiles were indicative of an acute inflammatory response. Increased liver enzymes were observed shortly after exposure. Taken together, these factors suggest that the cynomolgus monkey is a reliable animal model for human disease.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fiebre Hemorrágica Ebola / Ebolavirus Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fiebre Hemorrágica Ebola / Ebolavirus Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos